Literature DB >> 32592327

Effect of immunosuppressive therapy on oxygen saturation and diameter of retinal vessels in initial onset acute uveitis associated with Vogt-Koyanagi-Harada disease.

Ahmed M Abu El-Asrar1,2, Mohammed D Alotaibi1, Priscilla W Gikandi1, Einar Stefánsson3,4.   

Abstract

PURPOSE: To demonstrate changes in oxygen saturation and calibre of retinal vessels in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada (VKH) disease at baseline and during immunosuppressive therapy.
METHODS: In this prospective study, 22 patients (44 eyes) were studied. Retinal oximetry measurements were performed using the noninvasive spectrophotometric retinal oximeter (Oxymap T1) at baseline and at 1-3 months, 4-6 months, 5-7 months and more than 9 months after treatment.
RESULTS: At baseline, mean logarithm of the minimum angle of resolution (logMAR) best-corrected visual acuity (BCVA) was 1.12 ± 0.78 (Snellen equivalent, 20/265). Arteriolar and venular oxygen saturations were 108 ± 7% and 70 ± 9%, respectively and calibres of arterioles and venules were 12.1 ± 1.1 pixels and 16.9 ± 1.4 pixels, respectively. At 4-6 months of follow-up, logMAR BCVA was almost maximum (0.08 ± 0.1, Snellen equivalent 20/24; p < 0.001) and thereafter remained almost unchanged. After immunosuppressive therapy, arteriolar and venular oxygen saturation values continued to decrease up to >9 months of follow-up (92 ± 7% and 56 ± 10%, respectively; p < 0.001 for both arterioles and venules). Similarly, arteriolar and venular calibres continued to decrease up to >9 months of follow-up to 11.4 ± 0.9 pixels (p = 0.006) and 15.6 ± 1.3 pixels (p = 0.001), respectively.
CONCLUSIONS: Eyes with initial-onset acute uveitis associated with VKH disease have increased oxygen saturation and calibres of retinal vessels at baseline. Immunosuppressive therapy normalizes these changes and in a similar pattern improves BCVA.
© 2020 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Vogt-Koyanagi-Harada disease; immunosuppressive therapy; retinal oximetry; retinal vessel oxygen saturation; uveitis

Year:  2020        PMID: 32592327     DOI: 10.1111/aos.14531

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  3 in total

1.  Alterations in ocular microcirculation and oxygen metabolism in patients with lipemia retinalis.

Authors:  Waleed K Alsarhani; Fadwa F Al Adel; Abdullah Alamri; Rahaf M Al Malawi; Abdulrahman F AlBloushi
Journal:  BMC Ophthalmol       Date:  2022-07-06       Impact factor: 2.086

Review 2.  Clinical implications of retinal oximetry in retinal vein occlusion: a review.

Authors:  Aditya V Belamkar; Sayena Jabbehdari; Alon Harris; Amir R Hajrasouliha
Journal:  Acta Ophthalmol       Date:  2021-11-29       Impact factor: 3.988

Review 3.  Vogt-Koyanagi-Harada disease: the step-by-step approach to a better understanding of clinicopathology, immunopathology, diagnosis, and management: a brief review.

Authors:  Cristhian A Urzua; Carl P Herbort; Masaru Takeuchi; Ariel Schlaen; Luz E Concha-Del-Rio; Yoshihiko Usui; Loreto Cuitino; Ioannis Papasavvas
Journal:  J Ophthalmic Inflamm Infect       Date:  2022-05-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.